4basebio UK Societas Share Forecast, Price & News

GBX 325.15
-7.35 (-2.21 %)
(As of 04/16/2021 03:28 PM ET)
Today's Range
Now: GBX 325.15
50-Day Range
MA: GBX 339.77
52-Week Range
Now: GBX 325.15
Volume5,919 shs
Average Volume9,567 shs
Market Capitalization£40.05 million
P/E RatioN/A
Dividend YieldN/A
4basebio UK Societas develops gene therapy technologies and solutions primarily in the United Kingdom. It focuses on the manufacture and supply of synthetic DNA and non-viral nanoparticles for research, therapeutic, and pharmacological use. The company provides services for biotech and pharma customers in the gene therapy and gene vaccine development. It is also involved in the manufacture of enzymes that are used for diagnostic and laboratory test kits. The company was formerly known as 4Basebio SE and changed its name to 4basebio UK Societas in December 2020. 4basebio UK Societas was incorporated in 2020 and is based in Cambridge, United Kingdom.

Industry, Sector and Symbol

Industry Biotechnology
Phone44 1223 967 943
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Market Cap£40.05 million
Next Earnings DateN/A
OptionableNot Optionable


No headlines for this company have been tracked by MarketBeat.com


Overall MarketRank

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
GBX 325.15
-7.35 (-2.21 %)
(As of 04/16/2021 03:28 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive 4BB News and Ratings via Email

Sign-up to receive the latest news and ratings for 4BB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

4basebio UK Societas (LON:4BB) Frequently Asked Questions

What stocks does MarketBeat like better than 4basebio UK Societas?

Wall Street analysts have given 4basebio UK Societas a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but 4basebio UK Societas wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of 4basebio UK Societas' key competitors?

What is 4basebio UK Societas' stock symbol?

4basebio UK Societas trades on the London Stock Exchange (LON) under the ticker symbol "4BB."

How do I buy shares of 4basebio UK Societas?

Shares of 4BB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is 4basebio UK Societas' stock price today?

One share of 4BB stock can currently be purchased for approximately GBX 325.15.

How much money does 4basebio UK Societas make?

4basebio UK Societas has a market capitalization of £40.05 million.

What is 4basebio UK Societas' official website?

The official website for 4basebio UK Societas is www.4basebio.com.

How can I contact 4basebio UK Societas?

The company can be reached via phone at 44 1223 967 943.

This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.